Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parent-to-Child Nasal Microbiota Transplant to Reestablish Nasal Microbiome Diversity After Intranasal Mupirocin Treatment of Children With Staphylococcus Aureus Nasal Colonization

NCT06805994 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06805994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06805994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parent-to-Child Nasal Microbiota Transplant to Reestablish Nasal Microbiome Diversity After Intranasal Mupirocin Treatment of Children With Staphylococcus Aureus Nasal Colonization
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Recruiting
Start date
August 27, 2025
Completion date
January 1, 2028
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbial colonization, microbial transplant, pediatric infection, s. aureus colonization, staphylococcal aureus infection